Animal skin wound disinfectant and preparation method thereof
By using three-dimensional modified polyvinylpyrrolidone and iodine powder, a long-term stable and low-irritating animal skin wound disinfectant was prepared, which solved the poor sterilization effect of existing halogen disinfectants in alkaline environments and traditional The problem of unstable iodine disinfectant has achieved a strong and low-irritating disinfection effect.
Patent Information
- Application Number
- CN202411111003.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-14
- Publication Date
- 2024-11-29
AI Technical Summary
Existing halogen disinfectants have poor bactericidal effect in alkaline environments, are easily affected by pH, and are irritating to the skin and mucosa. Traditional iodine disinfectants are unstable and easy to degrade, affecting the disinfection effect.
Three-dimensional modified polyvinylpyrrolidone is used to react with polyvinylpyrrolidone from three-dimensional porous graphene and chitosan as a carrier to form polymer compounds, combining iodine powder, reaction aids, stabilizers, surfactants, thickeners, and pH adjustment. and emollients to prepare a long-acting, stable and low-irritating animal skin wound disinfectant.
It improves the iodine content and stability of the disinfectant, enhances the bactericidal effect, reduces the irritation to the skin and mucosa, achieves a long-term disinfection effect, and is suitable for disinfection of livestock skin, nipples or skin mucosa.
Smart Images

Figure BDA0004992207730000121 
Figure BDA0004992207730000131
Abstract
Description
Technical Field
[0001] The present application belongs to the field of disinfectants, and specifically relates to an animal skin wound disinfectant and a preparation method thereof. Background Art
[0002] Halogen disinfectants include five elements: fluorine, chlorine, bromine, iodine, and astatine, as well as compounds (salts) formed by them and alkaline metal ions (magnesium, calcium ions, etc.). Halogen disinfectants can easily penetrate into bacterial cells to produce halogenation and oxidation effects on protoplasmic proteins, so they have strong bactericidal ability and are often used as medical disinfectants. The bactericidal effect of halogen disinfectants is mainly related to the effective halogen content. They have a broad antibacterial spectrum and a strong effect. They are effective against bacteria, spores, and viruses. They are currently one of the disinfectants with the longest application time, wide use, and ideal bactericidal effect.
[0003] Halogen disinfectants mainly include: chlorine-containing disinfectants, bromine-containing disinfectants and iodine-containing disinfectants. Chlorine-containing disinfectants mainly include sodium hypochlorite, bleaching powder, trichloroisocyanuric acid, etc., which play a bactericidal role in a non-dissociated form, so the bactericidal effect is better in an acidic environment, but worse in an alkaline environment, and is easily affected by reducing substances and pH. This type of halogen disinfectant partially dissolves in water or ethanol, absorbs moisture and carbon dioxide in the air and slowly decomposes, losing effective chlorine, so it needs to be sealed and stored in a cool and dry place. In addition, bleaching powder has an irritating effect on the skin and mucous membranes, corrosive effect on metals, and can fade colored cotton fabrics. This type of disinfectant is mainly used for environmental insecticide disinfection and has certain hazards to humans and animals. At present, bromine-containing disinfectants on the market include dibromodimethylamine, bromochlorodimethylamine, bromoisocyanuric acid, etc., and their bactericidal effects are similar to those of chlorine-containing disinfectants, but bromine-containing disinfectants are expensive, so they are rarely used in livestock and poultry disinfection.
[0004] Iodine-containing disinfectants usually include iodine tincture, iodine tincture, compound iodine preparations, etc., which have the ability to kill various bacteria, spores, viruses and fungi, and have a rapid effect. The active ingredient of iodine sterilization is free iodine, which is irritating to the skin and mucous membranes due to the influence of environmental pH; in addition, the presence of reducing substances in the solution leads to problems such as unstable solution and reduced disinfection effect. Summary of the invention
[0005] The purpose of the present application is to provide a long-lasting, stable and low-irritation animal skin wound disinfectant.
[0006] In order to achieve the above objectives, the technical solution adopted in this application is: to provide an animal skin wound disinfectant, the preparation raw materials are composed of iodine powder, three-dimensional modified polyvinyl pyrrolidone, reaction aids, stabilizers, thickeners, synergists, surfactants, pH adjusters and emollients, wherein the three-dimensional modified polyvinyl pyrrolidone is made of three-dimensional porous graphene, chitosan and polyvinyl pyrrolidone.
[0007] As a preference, the three-dimensional modified polyvinyl pyrrolidone is prepared by mixing polyvinyl pyrrolidone with a carrier, and the carrier is a mixture of three-dimensional porous graphene and chitosan.
[0008] As another preferred embodiment, the reaction aid is a mixture of oxalic acid and 2-hydroxysuccinic acid, the stabilizer is a mixture of potassium iodide and potassium iodate, the surfactant is a mixture of sodium dodecylbenzene sulfonate, Tween 20 and polyethylene glycol 200, and the pH adjuster is a mixture of citric acid and sodium hydroxide.
[0009] The present application also provides a method for preparing an animal skin wound disinfectant, comprising the following preparation steps: S1: reducing graphene oxide with a reducing agent to obtain three-dimensional porous graphene, mixing the three-dimensional porous graphene with chitosan to obtain a carrier, reacting the carrier with polyvinyl pyrrolidone to obtain a three-dimensional modified polyvinyl pyrrolidone as a product; S2: reacting iodine powder with the three-dimensional modified polyvinyl pyrrolidone in a solvent, and adding a reaction aid and a stabilizer to obtain a product, a povidone-iodine complex; S3: reacting the povidone-iodine complex, surfactant, thickener, pH regulator, synergist and emollient in a solvent, and sterilizing after cooling to obtain an animal skin wound disinfectant.
[0010] As another preference, the three-dimensional porous graphene and chitosan are mixed in a mass ratio of 1:(3-8) to obtain the carrier.
[0011] As another preference, the carrier and the polyvinyl pyrrolidone are mixed in a mass ratio of 1:(1-4).
[0012] As another preference, the iodine powder and the three-dimensional modified polyvinyl pyrrolidone are mixed in a mass ratio of 1:(1-10).
[0013] As another preferred embodiment, the added amount of the reaction aid is 0.5% to 1% of the total mass of the iodine powder and the three-dimensional modified polyvinyl pyrrolidone, and the added amount of the stabilizer is 0.5% to 2% of the total mass of the iodine powder and the three-dimensional modified polyvinyl pyrrolidone.
[0014] As another preference, the reaction aid is a mixture of oxalic acid and 2-hydroxysuccinic acid in a mass ratio of 1:(1-2), and the stabilizer is a mixture of potassium iodide and potassium iodate in a mass ratio of (10-5):1.
[0015] Further preferably, in the S3 step, the animal skin wound disinfectant of different concentrations is prepared by adjusting the content of the povidone-iodine complex, wherein the thickener is added in an amount of 0.1% to 0.2% of the total mass of the animal skin wound disinfectant, the synergist is added in an amount of 0.1% to 0.5% of the total mass of the animal skin wound disinfectant, the surfactant is added in an amount of 0.1% to 1% of the total mass of the animal skin wound disinfectant, the pH regulator is added in an amount of 0.2% to 0.6% of the total mass of the animal skin wound disinfectant, and the emollient is added in an amount of 0.05% to 0.2% of the total mass of the animal skin wound disinfectant.
[0016] Compared with the prior art, the beneficial effects of this application are:
[0017] (1) The animal skin wound disinfectant of the present application uses three-dimensional porous graphene and chitosan as carriers, and polyvinyl pyrrolidone is polymerized on the carrier. The three-dimensional porous graphene structure effectively increases the exposed amino sites and provides more loading sites for iodine, thereby effectively increasing the iodine content and increasing the bactericidal and disinfecting effect of the animal skin wound disinfectant;
[0018] (2) Polyvinyl pyrrolidone is cross-linked with the three-dimensional porous carrier to form a high molecular compound with high molecular bond energy, which provides a more solid and less easily replaced carrier complex for the subsequent iodine, helps to enhance the stability of the animal skin wound disinfectant and maintain a long-term bactericidal and disinfecting effect;
[0019] (3) The animal skin wound disinfectant of the present application increases the stability of the animal skin wound disinfectant through the synergistic effect of surfactants, thickeners, synergists, pH regulators and emollients, and effectively solves the irritation of traditional povidone-iodine solutions to the skin and mucous membranes. DETAILED DESCRIPTION
[0020] Below, the present application is further described in conjunction with specific implementation methods. It should be noted that, under the premise of no conflict, the various embodiments or technical features described below can be arbitrarily combined to form new embodiments.
[0021] The terms "including" and "having" and any variations thereof in the specification and claims of this application are intended to cover non-exclusive inclusions. For example, a process, method, system, product or apparatus comprising a series of steps or units is not necessarily limited to those steps or units explicitly listed, but may include other steps or units not explicitly listed or inherent to these processes, methods, products or apparatuses.
[0022] The animal skin wound disinfectant of the present application comprises raw materials for preparation including iodine powder, three-dimensional modified polyvinyl pyrrolidone, reaction aid, stabilizer, thickener, synergist, surfactant, pH regulator and emollient.
[0023] The main active ingredient of animal skin wound disinfectant is modified povidone iodine, an amorphous soluble complex formed by modified polyvinyl pyrrolidone and iodine, in which polyvinyl pyrrolidone is a three-dimensionally modified polyvinyl pyrrolidone. The corrosiveness of iodine is the weakest among non-radioactive hydrofluoric acid. In addition, among other halogen elements, such as fluorine, chlorine, and bromine, the corrosiveness and toxicity are stronger than iodine.
[0024] The modified animal skin wound disinfectant prepared in the present application continuously releases free iodine to exert antibacterial effects, causing bacterial proteins to deform and die, and has a bactericidal effect on bacteria, fungi and viruses. The animal skin wound disinfectant has a strong broad-spectrum bactericidal effect, fast action, low toxicity, low cost, no irritation and no corrosion, and can be widely used in the disinfection of livestock skin, nipples or skin mucosa and wounds.
[0025] The three-dimensional modified polyvinyl pyrrolidone of the present application uses three-dimensional porous graphene and chitosan as carriers, and polymerizes polyvinyl pyrrolidone on the carrier to increase exposed amino sites. The three-dimensional porous graphene structure provides more loading sites for iodine, thereby increasing the effective content of iodine and enhancing the bactericidal effect of the disinfectant.
[0026] In addition, three-dimensional modified polyvinyl pyrrolidone is a high molecular compound with high molecular bond energy formed by cross-linking three-dimensional porous graphene and chitosan, which provides a more solid and non-replaceable carrier complex for iodine. It also has a solubilizing effect, making the bactericide more stable and maintaining a long-lasting bactericidal effect.
[0027] Polyvinyl pyrrolidone is a non-ionic polymer compound. It has developed into three major categories: non-ionic, cationic, and anionic. It has three specifications: industrial grade, pharmaceutical grade, and food grade. It has a series of homopolymers, copolymers, and cross-linked polymers with relative molecular weights ranging from thousands to more than one million. It has been widely used for its excellent and unique properties. Polyvinyl pyrrolidone has excellent physiological inertness, does not participate in human metabolism, and has excellent biocompatibility. It does not cause any irritation to the skin, mucous membranes, eyes, etc. Pharmaceutical grade polyvinyl pyrrolidone is one of the three major new pharmaceutical excipients advocated by the international community. It can be used as a binder for tablets and granules, a solubilizer for injections, a flow aid for capsules, a detoxifier for eye drops, a delay agent, a lubricant and a coating film-forming agent, a dispersant for liquid preparations, and a stabilizer for enzymes and heat-sensitive drugs. It can also be used as a cryopreservative.
[0028] The polyvinyl pyrrolidone of the present invention is not particularly limited and can be sold in the market or synthesized in the laboratory. Preferably, the polyvinyl pyrrolidone is one or more of polyvinyl pyrrolidone K15, polyvinyl pyrrolidone K30, polyvinyl pyrrolidone K60 and polyvinyl pyrrolidone K90.
[0029] The molecular weight of polyvinyl pyrrolidone is 8000-700000, and it is usually expressed as K value. Different K values represent the corresponding average molecular weight range of polyvinyl pyrrolidone. K value is actually a characteristic value related to the relative viscosity of polyvinyl pyrrolidone aqueous solution, and viscosity is a physical quantity related to the molecular weight of polymer, so K value can be used to characterize the average molecular weight of polyvinyl pyrrolidone. Generally, the larger the K value, the greater the viscosity and the stronger the adhesion. Commercially available polyvinyl pyrrolidone is divided into four viscosity grades according to K value: K-15, K-30, K-60, K-90, and their number average relative molecular mass is 10000, 40000, 160000 and 360000 respectively. Due to hydrogen bonding or complexation, the viscosity of polyvinyl pyrrolidone increases, thereby inhibiting the formation and growth of drug crystal nuclei, making the drug amorphous, making it have excellent physiological inertness and biocompatibility, non-irritating to the skin and eyes, harmless and non-toxic.
[0030] In some embodiments, the reaction aid may be, but is not limited to, a mixture of one or more of oxalic acid, formic acid, ammonium bicarbonate, sodium bicarbonate, and 2-hydroxysuccinic acid.
[0031] In some embodiments, the stabilizer is potassium iodide or potassium iodate, or a mixture of the two. In a preferred embodiment, the stabilizer is a mixture of potassium iodide and potassium iodate.
[0032] Potassium iodide and potassium iodate can inhibit the degradation of iodine in the preparation process of the modified povidone-iodine complex, improve the stability of iodine in the povidone-iodine complex, and effectively increase the iodine content of the complex. At the same time, the stabilizer and the reaction aid have a synergistic effect, which is beneficial to prevent the loss of iodine in the complex and increase the stability of the povidone-iodine solution.
[0033] Thickener refers to a new type of functional polymer material used to increase the viscosity or consistency of products. It has the characteristics of small dosage, obvious thickening, and easy use. It is widely used in pharmaceutical, cosmetic, food additive, papermaking and other industries. There are many substances that can be used as thickeners, and the types of thickeners vary with different applications. Generally, thickeners are divided into low molecular thickeners and high molecular thickeners according to relative molecular mass; they are divided into four categories according to functional groups: inorganic thickeners, cellulose, polyacrylate thickeners and associative polyurethane thickeners.
[0034] In some embodiments, the thickener may be, but is not limited to, one or a combination of sodium carboxymethyl cellulose, sodium alginate, hydroxypropyl methylcellulose K15M, hydroxypropyl methylcellulose K4M, and polyvinyl alcohol.
[0035] The present invention increases the viscosity of the solution by adding a thickener, resulting in a decrease in the movement speed of molecules, thereby restricting the movement of molecules or particles in the solution, reducing the chance of effective collision between molecules, and thus reducing the iodine decomposition reaction speed and the iodine sublimation escape speed, thereby improving the stability of the solution.
[0036] In some preferred embodiments, the thickener is sodium hydroxymethylcellulose.
[0037] Surfactant refers to a substance that can significantly change the interfacial state of its solution system by adding a small amount. It has fixed hydrophilic and lipophilic groups and can be arranged in a directional manner on the surface of the solution. The molecular structure of surfactant is amphiphilic: one end is a hydrophilic group and the other end is a hydrophobic group; the hydrophilic group is often a polar group, such as carboxylic acid, sulfonic acid, sulfuric acid, amino or amine group and its salt, hydroxyl, amide, ether bond, etc. can also be used as polar hydrophilic groups; while the hydrophobic group is often a non-polar hydrocarbon chain, such as a hydrocarbon chain with more than 8 carbon atoms. Surfactants are divided into ionic surfactants (including cationic surfactants and anionic surfactants), non-ionic surfactants, zwitterionic surfactants, other surfactants, etc. Non-ionic surfactants include: Tween 20, Tween 80, polyethylene glycol 200, polyethylene glycol 600, polyethylene glycol 2000, nonylphenol polyoxyethylene ether, poloxamer 188, poloxamer 407, etc.; cationic surfactants include sodium dodecyl sulfate, sodium dodecylbenzene sulfonate, sodium fatty alcohol polyoxyethylene ether sulfate, etc.; zwitterionic surfactants such as sodium dodecyl sulfate betaine; cationic surfactants include hexadecyltrimethylammonium bromide, dodecyltrimethylammonium bromide, etc.
[0038] Nonionic surfactants are surfactants that do not ionize in aqueous solution, and their hydrophilic groups are mainly composed of a certain number of oxygen-containing groups (generally ether groups and hydroxyl groups). This is why nonionic surfactants are superior to ionic surfactants in some aspects; because they are not in an ionic state in the solution, they are highly stable, not easily affected by the presence of strong electrolyte inorganic salts, nor by pH values, and have good compatibility with other types of surfactants.
[0039] In some embodiments, the surfactant can be, but is not limited to, Tween 20, Tween 80, polyethylene glycol 200, polyethylene glycol 600, polyethylene glycol 2000, nonylphenol polyoxyethylene ether, poloxamer 188, poloxamer 407, sodium dodecyl sulfate, sodium dodecylbenzene sulfonate, sodium fatty alcohol polyoxyethylene ether sulfate, sodium dodecyl sulfate betaine, hexadecyltrimethylammonium bromide, and a combination of one or more of dodecyltrimethylammonium bromide.
[0040] In a more preferred embodiment, the surfactant is a mixture of sodium dodecylbenzene sulfonate, Tween 20 and polyvinyl alcohol 200.
[0041] Surfactants have a certain stabilizing effect on povidone-iodine solution. The reason is that the adsorption effect of surfactants forms a molecular film around the povidone-iodine molecules, thereby forming a barrier layer to prevent collision, aggregation and sedimentation between particles, thereby inhibiting the dissociation of iodine from povidone-iodine and the degradation of iodine, which is the steric hindrance of surfactants.
[0042] pH regulator is a general term for acids, alkalis, and salts that enhance the sour taste of food and adjust pH or have a buffering effect, such as phosphates, phthalates, borax, sodium hydroxide, sodium bicarbonate, etc. Commonly used acidity regulators include citric acid, potassium citrate, lactic acid, tartaric acid, malic acid, sodium citrate, potassium citrate, etc., among which citric acid is the most widely used. pH regulators can enhance the stability of solutions.
[0043] In some preferred embodiments, the pH adjuster may be, but is not limited to, a combination of one or more of phosphates, phthalates, sodium hydroxide, citric acid, potassium citrate, lactic acid, tartaric acid, malic acid, sodium citrate, and potassium citrate.
[0044] In a more preferred embodiment, the pH adjuster is a mixture of citric acid and sodium hydroxide.
[0045] In some embodiments, the enhancer is gum arabic.
[0046] Gum arabic has high solubility and low viscosity, which effectively promotes the dissolution of povidone-iodine complex. In addition, gum arabic carries acidic groups in its structure, and its aqueous solution is also weakly acidic, which has acid environment stability and can further inhibit the degradation of iodine into iodide ions, thereby improving the stability of povidone-iodine solution.
[0047] In some embodiments, the emollient may be, but is not limited to, a combination of one or more of glycerin, propylene glycol, water-soluble lanolin, polyethylene glycol, sorbitol, and hyaluronic acid.
[0048] In a more preferred embodiment, the emollient is hyaluronic acid.
[0049] The animal skin wound disinfectant prepared in the present application uses the synergistic effect of iodine, three-dimensional modified polyvinyl pyrrolidone and other additives to increase the content of effective iodine and the stability of the disinfectant, reduce the damage of the disinfectant to animals, avoid the irritation of the disinfectant to the skin and mucous membranes, and enhance the bactericidal and disinfecting efficacy of the disinfectant.
[0050] The animal skin wound disinfectant prepared by the present application has the characteristics of strong broad-spectrum bactericidal ability, low toxicity, no odor, low irritation, low corrosiveness, etc., and is suitable for the sterilization and disinfection of livestock. The animal skin wound disinfectant of the present application at a concentration of 5% can be used for skin disinfection and treatment of skin diseases; the animal skin wound disinfectant of the present application at a concentration of 0.5% to 1% can be used for immersion disinfection of cow nipples; the animal skin wound disinfectant of the present application at a concentration of 0.1% can be used for flushing of mucous membranes and wounds.
[0051] The present application also provides a method for preparing an animal skin wound disinfectant, comprising the following steps:
[0052] S1: reducing graphene oxide with a reducing agent to obtain three-dimensional porous graphene; mixing the three-dimensional porous graphene with chitosan to obtain a carrier, reacting polyvinyl pyrrolidone with the carrier to obtain a three-dimensional modified polyvinyl pyrrolidone;
[0053] S2: reacting iodine powder with three-dimensional modified polyvinyl pyrrolidone, and adding a reaction aid, a stabilizer and a solvent to obtain a povidone-iodine complex after the reaction is completed;
[0054] S3: reacting the povidone-iodine complex, surfactant, thickener, pH regulator, synergist and emollient together in a solvent, cooling and sterilizing to obtain an animal skin wound disinfectant.
[0055] In some embodiments, graphene oxide is prepared according to the Hummers method.
[0056] In some embodiments, trisodium citrate and thiourea are used to reduce graphene oxide. The specific steps are: use deionized water to make the graphene oxide, sodium citrate and thiourea constant volume, ultrasonicate for 2 to 3 minutes and transfer the suspension to a reactor, react at 160 to 200 ° C for 10 to 12 hours, filter the product and freeze-dry the product for two days to obtain three-dimensional porous graphene.
[0057] In some embodiments, the three-dimensional porous graphene and chitosan are mixed in a mass ratio of 1:(3-8) to obtain a carrier. Preferably, the three-dimensional porous graphene and chitosan are mixed in a mass ratio of 1:6.
[0058] In some embodiments, polyvinyl pyrrolidone and the carrier are mixed and reacted in a mass ratio of (1-4): 1. Preferably, the mass ratio of polyvinyl pyrrolidone to the carrier is 4:1.
[0059] In some embodiments, the mass ratio of iodine powder to three-dimensional modified polyvinyl pyrrolidone is 1:(1-10), and more preferably, the mass ratio of iodine powder to three-dimensional modified polyvinyl pyrrolidone is 1:(3-6).
[0060] In some embodiments, the amount of the reaction aid added is 0.5% to 1% of the sum of the mass of the iodine powder and the three-dimensional modified polyvinyl pyrrolidone, and the amount of the stabilizer added is 0.5% to 2% of the sum of the mass of the iodine powder and the three-dimensional modified polyvinyl pyrrolidone.
[0061] In some embodiments, the reaction aid is a mixture of oxalic acid and 2-hydroxysuccinic acid, and the mass ratio of oxalic acid to 2-hydroxysuccinic acid is 1:(1-2).
[0062] In some embodiments, the stabilizer is a mixture of potassium iodide and potassium iodate, and the mass ratio of potassium iodide to potassium iodate is (10-5):1.
[0063] In some embodiments, the added amount of the thickener is 0.1% to 0.2% of the total mass of the animal skin wound disinfectant, the added amount of the synergist is 0.1% to 0.5% of the total mass of the animal skin wound disinfectant, the added amount of the surfactant is 0.1% to 1% of the total mass of the animal skin wound disinfectant, the added amount of the pH adjuster is 0.2% to 0.6% of the total mass of the animal skin wound disinfectant, and the added amount of the emollient is 0.05% to 0.2% of the total mass of the animal skin wound disinfectant.
[0064] In some embodiments, step S3 is to mix the povidone-iodine complex, surfactant, thickener, pH adjuster, synergist and emollient in purified water, wherein the amount of the povidone-iodine complex added is adjusted to prepare animal skin wound disinfectants of different concentrations.
[0065] Example 1
[0066] S1: Grind the dried graphene oxide thoroughly, weigh 300 mg of graphene oxide and add it to a beaker, add 20 mL of 1% trisodium citrate and 1.8 g of thiourea, dilute to 50 mL with deionized water, and then ultrasonicate for 2 to 3 minutes. Transfer the ultrasonicated solution to a reactor, react at 180°C for 12 hours, cool to room temperature, centrifuge to obtain the product, wash it 3 times with deionized water, and freeze-dry the product for 24 hours to obtain three-dimensional porous graphene.
[0067] 10 mg of three-dimensional porous graphene and 60 mg of chitosan were mixed evenly to obtain a carrier; 40 mg of polyvinyl pyrrolidone K30 and 10 mg of the carrier were mixed evenly and reacted at 180° C. for 12 h, and the product was dried to obtain a three-dimensional modified polyvinyl pyrrolidone;
[0068] S2: Weigh 10 mg of iodine powder and 50 mg of three-dimensional modified polyvinyl pyrrolidone, grind and add to a reaction container, add 0.3 mg of oxalic acid, 0.3 mg of 2-hydroxysuccinic acid, 1.09 mg of potassium iodide and 0.11 mg of potassium iodate to the reaction container, add anhydrous ethanol to the reaction container and stir evenly at room temperature, place the reaction container in an oil bath and slowly heat it to 45° C. and stir for 2 h, slowly increase the oil bath temperature to 75° C. and stir for 2 h, and then slowly increase the oil bath temperature to 95° C. and stir for 12 h to obtain a povidone-iodine complex;
[0069] S3: Add 50 g of povidone-iodine complex, 0.5 g of sodium dodecylbenzene sulfonate, 0.5 g of Tween 20, 0.5 g of polyethylene glycol 200, 1 g of sodium hydroxymethylcellulose, 3.5 g of citric acid, 1.2 g of sodium hydroxide, 1.5 g of colloidal gum arabic and 1 g of hyaluronic acid to 940.3 mL of purified water, stir at 50°C for 30 min, cool and sterilize to obtain a 5% animal skin wound disinfectant.
[0070] Example 2
[0071] In step S1, 10 mg of three-dimensional porous graphene and 30 mg of chitosan were weighed and mixed evenly to obtain a carrier; the remaining preparation steps were consistent with the preparation steps in Example 1.
[0072] Example 3
[0073] In step S1, after the three-dimensional porous graphene and the carrier are prepared, 20 mg of polyvinyl pyrrolidone K30 and 10 mg of the carrier are uniformly mixed, and the remaining preparation steps are consistent with the preparation steps in Example 1.
[0074] Example 4
[0075] In step S2, 10 mg of iodine powder and 60 mg of three-dimensional modified polyvinyl pyrrolidone were weighed and ground, and 0.35 mg of oxalic acid, 0.35 mg of 2-hydroxysuccinic acid, 1.27 mg of potassium iodide and 0.13 mg of potassium iodate were added. The remaining preparation steps were consistent with the preparation steps in Example 1.
[0076] Example 5
[0077] In step S2, the masses of the reaction aids oxalic acid and 2-hydroxysuccinic acid are adjusted to: 0.2 mg oxalic acid and 0.4 mg 2-hydroxysuccinic acid, that is, the mass ratio of oxalic acid to 2-hydroxysuccinic acid is adjusted to 1:2, and the remaining preparation steps are consistent with the preparation steps in Example 1.
[0078] Example 6
[0079] In step S2, the masses of the stabilizers potassium iodide and potassium iodate are adjusted to: 1 mg potassium iodide and 0.2 mg potassium iodate, that is, the addition ratio of potassium iodide and potassium iodate is adjusted to 5:1, and the remaining preparation steps are consistent with the preparation steps in Example 1.
[0080] Example 7
[0081] In step S3, the amount of povidone-iodine complex added was adjusted to 1 g, the amount of purified water used was adjusted to 989.3 mL, and the remaining preparation steps were consistent with the preparation steps in Example 1, and finally a 0.1% animal skin wound disinfectant was prepared.
[0082] Example 8
[0083] In step S3, the amount of povidone-iodine complex added was adjusted to 8 g, the amount of purified water used was adjusted to 982.3 mL, and the remaining preparation steps were consistent with the preparation steps in Example 1, and finally a 0.8% animal skin wound disinfectant was prepared.
[0084] Example 9
[0085] In step S1, the three-dimensional porous graphene and chitosan are uniformly mixed to obtain a carrier, 20 mg of polyvinyl pyrrolidone K90 is uniformly mixed with 10 mg of the carrier, and the remaining preparation steps are consistent with the preparation steps in Example 1.
[0086] Comparative Example 1
[0087] Weigh 10 mg of iodine powder and 50 mg of commercially available polyvinyl pyrrolidone K30 and add them to a reaction container, add anhydrous ethanol to the reaction container and stir evenly at room temperature, place the reaction container in an oil bath and slowly heat it to 45° C. and stir for 2 h, slowly increase the oil bath temperature to 75° C. and stir for 2 h, and then slowly increase the oil bath temperature to 95° C. and stir for 12 h to obtain a complex;
[0088] 50 g of the complex, 0.5 g of sodium dodecylbenzene sulfonate, 0.5 g of Tween 20, 0.5 g of polyethylene glycol 200, 1 g of sodium hydroxymethylcellulose, 3.5 g of citric acid, 1.2 g of sodium hydroxide, 1.5 g of gum arabic and 1 g of hyaluronic acid were added to 940.3 mL of purified water, stirred at 50°C for 30 min, cooled and sterilized to obtain disinfectant A.
[0089] Comparative Example 2
[0090] In step S2, only oxalic acid is added as a reaction aid, that is, 10 mg of iodine powder and 50 mg of three-dimensional modified polyvinyl pyrrolidone are weighed, ground and added to a reaction container, and 0.6 mg of oxalic acid, 1.09 mg of potassium iodide and 0.11 mg of potassium iodate are added to the reaction container. The remaining preparation steps are consistent with the preparation steps in Example 1.
[0091] Comparative Example 3
[0092] In step S3, sodium dodecylbenzene sulfonate, Tween 20, and polyethylene glycol 200 were removed, and the amount of purified water added was adjusted to 941.8 mL. The remaining preparation steps were consistent with the preparation steps in Example 1.
[0093] Comparative Example 4
[0094] In step S3, 0.5 g of sodium dodecylbenzenesulfonate was replaced with 0.5 g of hexadecyltrimethylammonium bromide, and the remaining preparation steps were consistent with the preparation steps in Example 1.
[0095] Comparative Example 5
[0096] In step S3, 0.5 g of sodium dodecylbenzene sulfonate was replaced by 0.5 g of hexadecyltrimethylammonium bromide, and 1 g of sodium hydroxymethylcellulose was replaced by 1 g of hydroxypropylmethylcellulose K15M. The remaining preparation steps were consistent with the preparation steps in Example 1.
[0097] Comparative Example 6
[0098] In step S3, 0.5 g of sodium dodecylbenzene sulfonate was replaced with 0.5 g of hexadecyltrimethylammonium bromide, the gum arabic was removed, the amount of purified water added was adjusted to 941.8 mL, and the remaining preparation steps were consistent with the preparation steps in Example 1.
[0099] Performance Evaluation
[0100] 1. Determination of iodine content: Take 4 g of the disinfectant prepared in Examples 1 to 9 and Comparative Examples 1 to 6 respectively in a container, add 75 mL of water, titrate with 0.01 mol / L sodium thiosulfate titrant according to the potentiometric titration method, and calculate the iodine content.
[0101] 2. Irritation test: According to the technical specifications for toxicological experiments of disinfection products in the Technical Specifications for Disinfection, the animal skin wound disinfectants described in Examples 1 to 9 were subjected to irritation tests on the skin, eyes, nipples and mucous membranes of New Zealand rabbits.
[0102] 3. Determination of bactericidal efficacy: Under aseptic operation conditions, take 3-14 generations of Staphylococcus aureus ATCC6538 nutrient agar slants, add 3-15 mL of sterilized diluent (0.9% sodium chloride + 0.1% trypsin) to wash the bacterial lawn, transfer the washing liquid to another sterile test tube to obtain a bacterial suspension with a concentration of 5×108 cfu / ml.
[0103] Take a sterile test tube, first add 0.5mL of the test bacterial suspension, then add 0.5mL of the organic interfering substance, mix well, place in a 25±1℃ water bath for 5min, use a sterile pipette to draw 4.0mL of the disinfectant prepared in Examples 1 to 9 and Comparative Examples 1 to 6 and inject it, quickly mix well and immediately count. After the test bacteria interact with each disinfectant for each predetermined time (15s, 30s, 1min, 2min), draw 0.5mL of the above mixed solution respectively and add it to 4.5mL of the sterilized neutralizer (0.6% sodium thiosulfate + 2% Tween 80 + 1% lecithin), mix well. After 10min of neutralization, draw 1.0mL of the sample solution respectively, culture in a 37℃ incubator for 48h, and determine the number of surviving bacteria according to the live bacteria culture counting method.
[0104] The above test results are recorded in Table 1 below.
[0105] Table 1 Performance test results of each embodiment and each comparative example
[0106] Analyzing the iodine content data in Table 1, it can be seen from the results of Example 1 and Comparative Examples 1 to 6 that the scheme of the present application prepares a 5% animal skin wound disinfectant from three-dimensional modified polyvinyl pyrrolidone, which can complex more iodine and inhibit the degradation process of iodine, thereby improving the stability of the povidone-iodine solution and the utilization rate of effective iodine, thereby improving the bactericidal and disinfection performance of the povidone-iodine disinfectant.
[0107] The animal skin wound disinfectant prepared in the present application was subjected to an irritation test on the skin, eyes, nipples and mucous membranes of New Zealand rabbits. No abnormal reactions such as erythema and edema were observed on the rabbit skin, and the skin irritation index of the three concentrations of povidone iodine disinfectant was 0.0; slight redness appeared on the mucous membranes and nipples of some rabbits, and the results of histopathological observations showed that it was extremely mildly irritating. The mucous membrane irritation index of the 5% animal skin wound disinfectant was 3.0, and the nipple irritation index was 2.0.
[0108] The present application increases the stability of the animal skin wound disinfectant through the synergy of surfactants, thickeners, synergists, pH regulators and emollients, and effectively solves the irritation of the traditional povidone-iodine solution to the skin and mucous membranes. The 5% animal skin wound disinfectant prepared in the present application is suitable for skin disinfection and treatment of skin diseases, the 0.1% animal skin wound disinfectant is suitable for mucosal disinfection and wound washing, and the 0.5% to 1% animal skin wound disinfectant is suitable for immersion disinfection of cow nipples.
[0109] The above describes the basic principles, main features and advantages of the present application. Those skilled in the art should understand that the present application is not limited by the above embodiments, and the above embodiments and the specification only describe the principles of the present application. The present application may have various changes and improvements without departing from the spirit and scope of the present application, and these changes and improvements fall within the scope of the present application for which protection is sought. The scope of protection claimed by the present application is defined by the attached claims and their equivalents.
Claims
1. A disinfectant for animal skin wounds, It is characterized in that The preparation raw materials consist of iodine powder, three-dimensional modified polyvinyl pyrrolidone, reaction aid, stabilizer, thickener, synergist, surfactant, pH regulator and emollient, wherein the three-dimensional modified polyvinyl pyrrolidone is made of three-dimensional porous graphene, chitosan and polyvinyl pyrrolidone.
2. The animal skin wound disinfectant as claimed in claim 1, It is characterized in that The three-dimensional modified polyvinyl pyrrolidone is prepared by mixing polyvinyl pyrrolidone with a carrier, and the carrier is a mixture of three-dimensional porous graphene and chitosan.
3. The animal skin wound disinfectant as claimed in claim 1, It is characterized in that The reaction aid is a mixture of oxalic acid and 2-hydroxysuccinic acid, the stabilizer is a mixture of potassium iodide and potassium iodate, the surfactant is a mixture of sodium dodecylbenzenesulfonate, Tween 20 and polyethylene glycol 200, and the pH regulator is a mixture of citric acid and sodium hydroxide.
4. A method for preparing an animal skin wound disinfectant, It is characterized in that The method comprises the following preparation steps: S1: reducing graphene oxide with a reducing agent to obtain three-dimensional porous graphene, mixing the three-dimensional porous graphene with chitosan to obtain a carrier, and reacting the carrier with polyvinyl pyrrolidone to obtain a product that is a three-dimensional modified polyvinyl pyrrolidone; S2: reacting iodine powder with the three-dimensional modified polyvinyl pyrrolidone in a solvent, and adding a reaction aid and a stabilizer to obtain a product, povidone-iodine complex; S3: reacting the povidone-iodine complex, surfactant, thickener, pH regulator, synergist and emollient in a solvent, and sterilizing after cooling to obtain an animal skin wound disinfectant.
5. The preparation method according to claim 4, It is characterized in that The three-dimensional porous graphene and chitosan are mixed in a mass ratio of 1:(3-8) to obtain the carrier.
6. The preparation method according to claim 4, It is characterized in that The carrier and the polyvinyl pyrrolidone are mixed in a mass ratio of 1:(1-4).
7. The preparation method according to claim 4, It is characterized in that The iodine powder and the three-dimensional modified polyvinyl pyrrolidone are mixed in a mass ratio of 1:(1-10).
8. The preparation method according to claim 4, It is characterized in that The added amount of the reaction aid is 0.5% to 1% of the total mass of the iodine powder and the three-dimensional modified polyvinyl pyrrolidone, and the added amount of the stabilizer is 0.5% to 2% of the total mass of the iodine powder and the three-dimensional modified polyvinyl pyrrolidone.
9. The preparation method according to claim 4, It is characterized in that The reaction aid is a mixture of oxalic acid and 2-hydroxysuccinic acid in a mass ratio of 1:(1-2), and the stabilizer is a mixture of potassium iodide and potassium iodate in a mass ratio of (10-5):
1.
10. The preparation method according to any one of claims 4 to 9, It is characterized in that In the step S3, the animal skin wound disinfectant of different concentrations is prepared by adjusting the content of the povidone-iodine complex, wherein the thickener is added in an amount of 0.1% to 0.2% of the total mass of the animal skin wound disinfectant, the synergist is added in an amount of 0.1% to 0.5% of the total mass of the animal skin wound disinfectant, the surfactant is added in an amount of 0.1% to 1% of the total mass of the animal skin wound disinfectant, the pH regulator is added in an amount of 0.2% to 0.6% of the total mass of the animal skin wound disinfectant, and the emollient is added in an amount of 0.05% to 0.2% of the total mass of the animal skin wound disinfectant.
